Skip to main content

Table 3 Genotype-phenotype association analysis for muscular subsystem gene polymorphisms and baseline aerobic power and changes after training in the CAREGENE study

From: A genetic predisposition score for muscular endophenotypes predicts the increase in aerobic power after training: the CAREGENE study

Gene

Polymorphism

Allele

Frequency

VO2pre

p-value

VO2change

p-value

VO2change

p-value

   

N (%)

(ml/min)a

 

(ml/min)b

 

(%) b

 

AMPD1

C34T/rs17602729

CC

652 (71)

1711 ± 15

p = 0.40

396 ± 10

p = 0.11

24.8 ± 0.6

p = 0.04

  

CT + TT

263 (29)

1734 ± 23

 

367 ± 16

 

22.4 ± 0.99

 

CNTF

G-6A/rs1800169

GG

664 (73)

1724 ± 15

p = 0.43

369 ± 9

p = 0.001

23.1 ± 0.6

p = 0.002

  

GA

226 (25)

1701 ± 25

 

416 ± 16

 

25.1 ± 1.0

 
  

AA

21 (2)

1801 ± 81

 

519 ± 52

 

33.9 ± 3.3

 

GR

R23K/rs6190

GG

857 (94)

1715 ± 13

p = 0.08

383 ± 9

p = 0.02

23.8 ± 0.6

p = 0.04

  

GA + AA

55 (6)

1805 ± 50

 

464 ± 34*

 

28.5 ± 2.2*

 
  1. AMPD1, Adenosine monophosphate deaminase; CNTF, Ciliary neurotrophic factor; GR, Glucocorticoid receptor
  2. a. Mean ± SE, corrected for gender, age, height and weight;
  3. b. Mean ± SE, corrected for gender, age, height, weight and baseline peakVO2